Subscribe
Contact Us
About Us
Advertise
Home
News
News from MM&M
Off the Wire
Newsletters
PMD Profiles
Agency Creative Showcase
Publication Connection
PMD Marketplace
Careers
About Us
Additional Resources
MM&M
MM&M Jobs
MAHF
Voi Consulting
Advertise
Subscribe
Get Listed
Additional Resources
RSS
|
Login
|
Register
Pharmaceutical Products
Pfizer and Wyeth to Divest Certain Animal Health Assets to Boehringer Ingelheim
September 21, 2009
Pfizer/Wyeth Transaction Expected to Close Early in the Fourth Quarter 2009
FDA Approves NovoLog(R) Labeling Update
July 15, 2009
Increases the Time Patients Can Use and Store NovoLog(R) in Their Pumps
Sciele Pharma Announces Availability of Ulesfia (Benzyl Alcohol Lotion 5%)
July 09, 2009
First Prescription Non-Neurotoxic Head Lice Treatment
Takeda Completes Acquisition of IDM Pharma, Inc.
June 24, 2009
Acquisition Adds MEPACT® to Takeda's Oncology Portfolio
New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus
June 23, 2009
Vaccine Against Canine Flu Granted Conditional License by USDA
FDA Grants The Medicines Company Pediatric Exclusivity for Angiomax(R)
June 19, 2009
Prospective Study Demonstrates Safety and Predictability of Angiomax in the Pediatric Population
Allergan Receives FDA Approval for OZURDEX Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease
June 18, 2009
First and Only Drug Therapy Indicated for Macular Edema Associated with Retinal Vein Occlusion (RVO)
Genzyme Receives European Approval of Renvela for Patients with Chronic Kidney Disease
June 12, 2009
Approval covers both the tablet and powder formulations
Cumberland Pharmaceuticals Announces FDA Approval of Caldolor(TM)
June 11, 2009
New drug is first injectable product approved for sale in the U.S. for treatment of pain and fever
MDRNA, Inc. Receives Full FDA Approval of Generic Calcitonin-Salmon Nasal Spray for Osteoporosis
June 09, 2009
Par Pharmaceutical Companies, Inc. Launches Product
Palomar Receives FDA Over-The-Counter Clearance for a Home Use Wrinkle Removal Laser Device
June 05, 2009
Clearance Opens Door To Multi-Billion Dollar Home Skin Care Market
FDA Approves First Canine Cancer Therapy
June 03, 2009
Pfizer Animal Health Receives Approval for PALLADIATM
Arbor Pharmaceuticals Announces the Launch of ZINOTIC ES
June 02, 2009
A New Extra Strength Product for the Treatment of Acute Otitis Externa
ARCA biopharma Receives Complete Response Letter From FDA on the GencaroTM NDA
June 01, 2009
FDA requires additional information
FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily
June 01, 2009
New Generation Treatment for Epilepsy
Bausch & Lomb Receives FDA Approval of Besivance(TM),
May 29, 2009
New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye')
Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder
May 29, 2009
Dey concludes the three-year agreement with Bristol-Myers
Access Pharmaceuticals Provides Update on Global Launch of MuGard(TM)
May 27, 2009
New FDA-Approved Treatment for Oral Mucositis
FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
May 26, 2009
Effective, convenient and economical therapy for PAH patients
NeurogesX Receives European Commission Approval for Qutenza(TM)
May 21, 2009
Approved for peripheral neuropathic pain in non-diabetic adults
Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
May 21, 2009
Bold and innovative marketing campaign will target women and highlight product's efficacy, ease of use and excellent tolerability
Pfizer Expands Its Generics Portfolio Through Innovative Licensing Deals, Increasing Access To Medicines For Billions Worldwide
May 20, 2009
More than 160 products will be available worldwide
Smith & Nephew Endoscopy Launches the BICEPTOR(TM) Tenodesis System
May 20, 2009
The First All-Arthroscopic Procedure for Biceps Tendon Repair
Merck to Launch TREDAPTIVE (ER niacin/laropiprant) in International Markets Later This Year
May 19, 2009
TREDAPTIVE is approved in 39 countries outside the U.S.
FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
May 18, 2009
RISPERDAL® CONSTA® is the First and Only Long-Acting Antipsychotic Therapy Available for Bipolar I Disorder
Takeda to Acquire IDM Pharma
May 18, 2009
Adds MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise
ConvaTec Launches New AQUACEL(R) Ag Dressing with Strengthening Fiber
May 14, 2009
Now 20 Times Stronger,* Advanced Ribbon Dressing Features Hydrofiber® Technology
Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
May 14, 2009
Acetavance would become the only approved intravenous agent for the treatment of fever in the U.S.
AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
May 13, 2009
Fixed-Dose Combination Offers a Convenient Option
Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
May 13, 2009
Licenses ADX-N05 from SK Holdings
Latest News
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Biodel Announces Name Change for Lead Product Candidate
Pfizer to Acquire FoldRx Pharmaceuticals
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
Medicis Announces Approval of Additional Strengths of Solodyn(R)
Meda acquires Alaven, a US specialty pharma company
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Most Popular
Most Emailed
Most Recent
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Novartis receives FDA approval of Tekamlo
Meda acquires Alaven, a US specialty pharma company
XenoPort Announces Changes to Executive Team
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
Pfizer to Acquire FoldRx Pharmaceuticals
Medicis Announces Approval of Additional Strengths of Solodyn(R)
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Meda acquires Alaven, a US specialty pharma company
Novo Nordisk Creates 'App' to Help Doctors Dose Insulin, Supporting New Trend in Diabetes Care
Biodel Announces Name Change for Lead Product Candidate
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
Medicis Announces Approval of Additional Strengths of Solodyn(R)
FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
Pfizer to Acquire FoldRx Pharmaceuticals
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Biodel Announces Name Change for Lead Product Candidate
Pfizer to Acquire FoldRx Pharmaceuticals
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
Medicis Announces Approval of Additional Strengths of Solodyn(R)
Meda acquires Alaven, a US specialty pharma company
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Popular Topics
Acquisition
Agency
Animal Health
Biopharmaceutical
Biotech
Business
Clinical Management
Collaboration
Diagnostic
Marketing & Communications
Medical Device
Medical Equipment
Merger
New Hire
New Hires
Personnel
Pharmaceutical
Pharmaceutical Products
Pipeline
Product Acquisition
Product Launch
Product Promotion
Regulatory
Regulatory Approval
Research & Development